Nicolas Lanthier

5.6k total citations
91 papers, 2.1k citations indexed

About

Nicolas Lanthier is a scholar working on Epidemiology, Physiology and Hepatology. According to data from OpenAlex, Nicolas Lanthier has authored 91 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Epidemiology, 27 papers in Physiology and 24 papers in Hepatology. Recurrent topics in Nicolas Lanthier's work include Liver Disease Diagnosis and Treatment (57 papers), Alcohol Consumption and Health Effects (19 papers) and Diet and metabolism studies (17 papers). Nicolas Lanthier is often cited by papers focused on Liver Disease Diagnosis and Treatment (57 papers), Alcohol Consumption and Health Effects (19 papers) and Diet and metabolism studies (17 papers). Nicolas Lanthier collaborates with scholars based in Belgium, United States and Switzerland. Nicolas Lanthier's co-authors include Isabelle Leclercq, Patrice D. Cani, Nico van Rooijen, Yves Horsmans, Olivier Molendi‐Coste, Nathalie M. Delzenne, Laure‐Alix Clerbaux, Audrey M. Neyrinck, Guido T. Bommer and Charles Burant and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Nicolas Lanthier

85 papers receiving 2.0k citations

Peers

Nicolas Lanthier

EPIDE

PHYSI

HEPAT

SURGE

Marica Meroni Italy

Lucia Russo United States

Simone Carotti Italy

Shvetank Sharma India

L. Trozzi Italy

Priya Handa United States

Toshiaki Nakano Japan

Jan Petrášek United States

Ariel E. Feldstein United States

Marica Meroni Italy

Nicolas Lanthier

1.6k ×1.7

EPIDE

670 ×0.9

342 ×0.7

PHYSI

532 ×1.2

HEPAT

400 ×1.0

SURGE

Citations per year, relative to Nicolas Lanthier Nicolas Lanthier (= 1×) peers Marica Meroni

Countries citing papers authored by Nicolas Lanthier

Since Specialization

Citations

This map shows the geographic impact of Nicolas Lanthier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Lanthier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Lanthier more than expected).

Fields of papers citing papers by Nicolas Lanthier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Lanthier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Lanthier. The network helps show where Nicolas Lanthier may publish in the future.

Co-authorship network of co-authors of Nicolas Lanthier

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Lanthier. A scholar is included among the top collaborators of Nicolas Lanthier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Lanthier. Nicolas Lanthier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stärkel, Peter, et al.. (2024). Patients with chronic liver diseases are at risk for diabetes even before development of cirrhosis. Clinics and Research in Hepatology and Gastroenterology. 48(8). 102428–102428.

Lanthier, Nicolas, et al.. (2024). Impact of Peroxisome Proliferator-Activated Receptor Agonists on Myosteatosis in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease. Discovery Medicine. 36(185). 1139–1139. 3 indexed citations

Froidure, Antoine, Paméla Baldin, Yves Horsmans, et al.. (2024). Pirfenidone-induced liver injury, a case report of a rare idiosyncratic reaction. Therapeutic Advances in Drug Safety. 15. 1591723090–1591723090. 2 indexed citations

Bozadjieva-Kramer, Nadejda, Jae Hoon Shin, Ziru Li, et al.. (2024). Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance. JCI Insight. 9(7). 7 indexed citations

Lanthier, Nicolas, et al.. (2023). Fibrosis and steatosis of the liver graft: Are non-invasive tests useful? A short review. Clinics and Research in Hepatology and Gastroenterology. 47(8). 102194–102194. 1 indexed citations

Pötgens, Sarah A., Audrey M. Neyrinck, Gabriela Salim de Castro, et al.. (2023). Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia. Journal of Cachexia Sarcopenia and Muscle. 14(3). 1569–1582. 11 indexed citations

Clerbaux, Laure‐Alix, Amalia Muñoz, Helena Soares, et al.. (2022). Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. Journal of Clinical Medicine. 11(19). 5691–5691. 13 indexed citations

Vos, M. De, Bénédicte Delire, Pierre Hainaut, et al.. (2022). Liver Decompensation after Bariatric Surgery in the Absence of Cirrhosis. Obesity Surgery. 32(4). 1227–1235. 7 indexed citations

Rodriguez, Julie, Audrey M. Neyrinck, Marco A. Gianfrancesco, et al.. (2022). Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individuals. BMC Medicine. 20(1). 110–110. 31 indexed citations

10.

Knudsen, Christelle, Audrey M. Neyrinck, Quentin Leyrolle, et al.. (2021). Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice. Journal of Nutrition. 151(6). 1507–1516. 39 indexed citations

11.

Komuta, Mina, et al.. (2020). Autoimmune hepatitis in a patient with thymectomy: the benefit of histology and MUM-1 immunostaining.. PubMed. 82(4). 550–551. 2 indexed citations

12.

Francque, Sven, Pierre Bédossa, Vlad Ratziu, et al.. (2020). The PanPPAR agonist lanifibranor induces both resolution of NASH and regression of fibrosis after 24 weeks of treatment in non-cirrhotic NASH: results of the NATIVE Phase 2b trial. Hepatology. 72. 18 indexed citations

13.

Restellini, Sophie, Nicolas Goossens, Sophie Clément, et al.. (2018). Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease. World Journal of Hepatology. 10(1). 73–81. 10 indexed citations

14.

Lanthier, Nicolas, Nathalie Lin-Marq, Laura Rubbia‐Brandt, et al.. (2017). Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?. Stem Cell Research & Therapy. 8(1). 88–88. 41 indexed citations

15.

Lanthier, Nicolas, Sylvain Terraz, Romain Bréguet, et al.. (2013). Computed tomography derived liver volume: a prognostic factor in decompensated alcoholic cirrhosis?. Acta gastro-enterologica belgica. 76. 12. 1 indexed citations

16.

Reny, Jean‐Luc, et al.. (2012). Intramural Hematoma of the Esophagus. Case Reports in Gastroenterology. 6(2). 510–517. 12 indexed citations

17.

Hul, Noémi Van, et al.. (2011). Kupffer Cells Influence Parenchymal Invasion and Phenotypic Orientation, but Not the Proliferation, of Liver Progenitor Cells in a Murine Model of Liver Injury. American Journal Of Pathology. 179(4). 1839–1850. 61 indexed citations

18.

Gerin, Isabelle, Laure‐Alix Clerbaux, Nicolas Lanthier, et al.. (2010). Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation*. Journal of Biological Chemistry. 285(44). 33652–33661. 304 indexed citations

19.

Lanthier, Nicolas, Yves Horsmans, & Isabelle Leclercq. (2009). The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis. Current Opinion in Clinical Nutrition & Metabolic Care. 12(4). 404–411. 39 indexed citations

20.

Lanthier, Nicolas, et al.. (2005). Infliximab in the treatment of posterior uveitis in Behçet's disease. La Presse Médicale. 34(13). 916–918. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact